We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Longitudinal Study of People Presenting for First Treatment of a Mood Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01529905
Recruitment Status : Unknown
Verified June 2005 by McMaster University.
Recruitment status was:  Recruiting
First Posted : February 9, 2012
Last Update Posted : February 9, 2012
Sponsor:
Collaborators:
Ontario Mental Health Foundation
Canadian Institutes of Health Research (CIHR)
AstraZeneca
Information provided by (Responsible Party):
McMaster University

Brief Summary:
The goal of this project is to study the course and outcome of illness in individuals who present with a first episode of depression or mania, or who have a recurrent disorder but have never received treatment. We plan to examine psychological, physical, social and environmental factors that may affect long-term outcome in these disorders

Condition or disease
Major Depression Bipolar Disorder

  Show Detailed Description

Study Type : Observational
Estimated Enrollment : 200 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Longitudinal Study of Individuals Presenting With a First Treated Episode of Depression of Mania (First Episode Project)
Study Start Date : June 1999
Primary Completion Date : September 2009
Estimated Study Completion Date : June 2014

Resource links provided by the National Library of Medicine

U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   16 Years to 50 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
patients who present to a tertiary care clinic for first treatment of depression or mania
Criteria

Inclusion Criteria:

  • Primary Mood Disorder,
  • Age 16-50
  • No previous treatment with psychotropic medication (may have had a max. of 5 days treatment with antidepressants/mood stabilizer &/or they may have Haldol &/or Lorazepam for clear restraint)

Exclusion Criteria:

  • History of CNS illness (except migraines),
  • Thyroid Disease,
  • Neoplastic illness
  • History of, or currently being treated for, Anorexia or Bulimia
  • History of Traumatic Brain Injury
  • Current treatment of Attention-Deficit Hyperactivity Disorder (ADHD)
  • Previous diagnosis of OCD or primary Anxiety disorder
  • Axis-II diagnosis that would suggest non-responsiveness to pharmacotherapy.
  • Substance dependence

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01529905


Contacts
Contact: Helen Begin, RN 905-522-1155 ext 5409 hbegin@stjosham.on.ca

Locations
Canada, Ontario
St. Joseph's Healthcare, Centre for Mountain Health Services Recruiting
Hamilton, Ontario, Canada, L8N 3K7
Contact: Helen Begin, RN    905-522-1155 ext 5426    hbegin@stjosham.on.ca   
Sponsors and Collaborators
McMaster University
Ontario Mental Health Foundation
Canadian Institutes of Health Research (CIHR)
AstraZeneca
Investigators
Principal Investigator: Glenda MacQueen, MD, PhD McMaster University